Effectiveness of mRNA COVID-19 Vaccines as First Booster Doses in England: An Observational Study in OpenSAFELY-TPP.
Elsie M F HorneWilliam J HulmeEdward P K ParkerRuth H KeoghElizabeth J WilliamsonVenexia M WalkerTom M PalmerRachel DenholmRochelle KnightHelen J CurtisAlex J WalkerColm D AndrewsAmir MehrkarJessica MorleyBrian MackennaSebastian C J BaconAlex J WalkerMiguel A HernánJonathan A C Sternenull nullPublished in: Epidemiology (Cambridge, Mass.) (2024)
We estimate that COVID-19 booster vaccination, compared with no booster vaccination, provided substantial protection against COVID-19 hospitalization and COVID-19 death but only limited protection against positive SARS-CoV-2 test. Lower rates of fracture in boosted than unboosted individuals may suggest unmeasured confounding. Observational studies should report estimated vaccine effectiveness against nontarget and negative control outcomes.